Latest Distributions News

Bioxyne Limited has reported a record $17.2 million in quarterly revenue, driven by strong growth in its cannabis and psychedelics segments, alongside strategic international expansions including a Frankfurt dual listing and new manufacturing agreements.

Stockland announces a 9-cent unfranked dividend for the half-year ending December 2025, alongside a Dividend Reinvestment Plan priced at $5.47 per security. The DRP offers investors a 1% discount and new securities issued will rank equally from the issue date.

Control Bionics has raised $3.8 million to fuel growth, forged a key distribution deal with Tobii, and integrated with Apple’s BCI protocol, while advancing its NeuroStrip and NeuroBounce platforms.

Bioxyne Limited has posted a record $17.2 million in quarterly revenue for Q2 FY26, driven by strong growth in its cannabis and psychedelics segments alongside strategic international expansions.

Tetratherix Limited (ASX, TTX) reports significant progress in clinical trials, strategic partnerships, and manufacturing capacity, positioning itself for near-term commercialisation and sustained innovation.

Gratifii Limited has reported its highest quarterly cash receipts to date, alongside progressing key acquisitions and completing a major client platform migration.

Clever Culture Systems has expanded its APAS Independence installed base to 27 instruments globally and surpassed $1 million in annual recurring revenue, underpinned by strong sales momentum and customer validation.

Nanoveu Limited has marked significant progress in its 16nm ECS-DoT edge-AI system-on-chip development, secured a strategic $7.5 million capital raise, and earned top honours at CES 2026, positioning itself for commercial breakthroughs in 2026.

Sun Silver Limited reports robust drilling results from its Maverick Springs Project, revealing mineralisation grades surpassing existing resources and highlighting significant antimony presence. These findings bolster the project's strategic appeal amid a strong silver market and critical minerals focus.

Firebrick Pharma has commenced commercial manufacturing and export of its new Nasodine Throat Spray, marking a significant step in its international expansion. The company also reported a 15% increase in cash sales and reduced operating costs, signalling improving financial health.

Everest Metals Corporation Ltd reported a cautious quarterly cash flow with net outflows from operations and investing, while securing a significant $18.6 million financing facility for its Mt Dimer project development.

BlackRock Investment Management (Australia) Limited has announced the distribution schedule for its Australian iShares ETFs, with key dates spanning early to mid-February 2026. Investors are reminded to update details and consider the Distribution Reinvestment Plan ahead of the record date.